Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

semiQ2 · Semiquantification based on ionization efficiency for human exposure leveraging ion mobility separation

HORIZONStatus: SIGNED16 September 202615 September 2028EU funding €209,915Call HORIZON-MSCA-2025-PF

Exposomics has revolutionized our understanding of how environmental factors influence diseases such as asthma, cancer, Alzheimer’s, Parkinson’s, and undiagnosed conditions. Exposure characterization enables epidemiologists to link biological pathways to disease outcomes. Contaminants of Emerging Concern (CECs), including industrial chemicals, pharmaceuticals, and persistent “forever chemicals,” are now commonly found in the environment and human samples. Detecting these compounds in biological matrices is not enough; quantification is essential to ensure their levels stay below thresholds associated with adverse health effects. Advances in liquid chromatography high-resolution mass spectrometry (LC-HRMS) have enhanced the targeted detection and quantification of CECs. However, this method depends on access to reference standards, which is impractical for non-target screening, where standards may be unavailable. Quantitative non-target screening (q-NTS) provides an alternative by offering concentration data for unknown compounds, enabling data interpretation beyond simple relative peak areas. We propose a new q-NTS approach optimized for human samples, using ion mobility separation to resolve co-elution issues. Employing LC-trapped ion mobility separation-HRMS (LC-TIMS-HRMS) and covering a broad range of CECs, our goal is to develop an LC-mobility resolved ionization efficiency (IE) model for both negative and positive electrospray ionization. These models will consider chemical structure, LC conditions (mobile phase and pH), adduct types, and signal areas from mobility versus intensity. TIMS is expected to reduce matrix complexity in biological samples, improving IE model accuracy and semiquantification. We will test the accuracy of these models using urine and blood samples from a prospective cohort of at least 60 participants (30 healthy and 30 patients). Risk assessment and prioritization of the detected CECs will utilize the generated semiquantitative data.

Consortium · 1 organisation

coordinator

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

ES · €209,915

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.